Document is current
Any future updates will be listed below
-
Authors
Koszela, Kamil https://orcid.org/0000-0003-3629-7523
Paradowska-Gorycka, Agnieszka https://orcid.org/0000-0002-4249-3136
Kwiatkowska, Brygida https://orcid.org/0000-0002-9622-1830
Woldańska-Okońska, Marta https://orcid.org/0000-0003-2884-2229
Stypińska, Barbara https://orcid.org/0000-0001-8179-8066
Ejma-Multański, Adam https://orcid.org/0009-0001-6062-1058
Gasik, Robert https://orcid.org/0000-0002-1947-2775
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct06807177 at ClinicalTrials.govDocuments that mention this clinical trial
Blood biomarkers of inflammation and brain-derived neurotrophic factor can not be used to assess the effectiveness of collagen mesotherapy in chronic cervical myofascial pain syndrome. A pilot single-blind randomized study
https://doi.org/10.1007/s00296-026-06094-4
-
Funding
Funding for this research was provided by:
Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im. Prof. dr hab. med. Eleonory Reicher (Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im. Prof. dr hab. med. Eleonory Reicher)
- License Information
-
More Information
Article History
Received: 3 February 2026
Accepted: 16 February 2026
First Online: 2 March 2026
Declarations
:
: The authors declare no conflicts of interest.
: The study was conducted in accordance with the Declaration of Helsinki and approved by the Bioethics Committee at the National Institute of Geriatrics, Rheumatology and Rehabilitation in Warsaw, Poland (approval number: KBT-5/7/2022, approval date: October 27, 2022).
